Efficacy, Immunogenicity and Safety of the AS04‐HPV‐16/18 Vaccine in Chinese Women Aged 18‐25 Years: End‐of‐study Results From a Phase II/III, Randomised, Controlled Trial

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2399
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

477. Phase I Safety and Immunogenicity of HPV 16 and 18 DNA Vaccines Delivered via Electroporation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Erratum To: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine

Open Forum Infectious Diseases
OncologyNeurology
2020English

Risk of Miscarriage With Bivalent Vaccine Against Human Papillomavirus (HPV) Types 16 and 18: Pooled Analysis of Two Randomised Controlled Trials

BMJ
2010English

Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults Aged 18–60 Years

Epidemiology and Vaccine Prevention
2018English

The Effect of Comprehensive Classes of Health Aerobics on Women Aged 18-25 Years

2019English

GTL001, a Therapeutic Vaccine for Women Infected With Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial

Clinical Cancer Research
Cancer ResearchOncology
2016English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine

Drugs
Pharmacology
2011English

Preschoolers in the Playground: A Pilot Cluster Randomised Controlled Trial of a Physical Activity Intervention for Children Aged 18 Months to 4 Years

Public Health Research
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy